Compare Axogen Inc (AXGN) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs Novartis AG — how do they compare? Axogen Inc trades at $48.21 (market cap $2.61B), while Novartis AG trades at $152.4 (market cap $295.37B). The key difference: Novartis AG is far larger — about 113.2× Axogen Inc's market cap, and Novartis AG pays a 3.07% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | NVS | |
|---|---|---|
Market Cap | $2.61B | $295.37B |
Sector | Technology | Health |
52-Week High | $48.48 | $168.62 |
52-Week Low | $14.16 | $119.31 |
Enterprise Value | $2.52B | $336.69B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
